Fig 1: U2 snRNP is connected to the U4/U6.U5 tri-snRNP in CE pre-B by three major bridges, and localization of U1 and the MINX exon.a, Fit of the pre-B model into the EM density of one pre-B protomer. On the left and right, enlargements of the major U2-tri-snRNP bridges are shown. Upper left, PRP4 kinase (PRP4K) bridges SF3B3WD40B with the HAT repeats of the U5 protein PRP6. Lower left, interaction of an α-helix of SF3A1 (aa 461-473) with the U5 snRNP protein DIM1 and the PRP8 helical bundle (PRP8HB). Right panels, two views of the U2/U6 helix II bridge with SF3B1 and SF3B6 at one end and the U6 Lsm ring at the other. In CI pre-B18,19 the tri-snRNP and U2 snRNP are also connected via the U2/U6 helix II and the SF3A1-DIM1/PRP8 interaction. PRP4K is docked to the tri-snRNP via U4/U6 stem II and PRP6HAT in both complexes, but its interaction with U2 SF3B3WD40B appears to be more flexible in CI pre-B, as EM density connecting the two proteins is observed in only a subset of CI pre-B complexes18. Guided by crosslinks (see panel b) we can place the RRM domain of SF3B6 at the C-terminal HEAT repeats of SF3B1 directly adjacent to U2/U6 helix II, consistent with the idea that SF3B6 may help to facilitate the formation of U2/U6 helix II during the initial interaction of the tri-snRNP with the spliceosome, in both the cross-intron and cross-exon assembly pathways. b, Cross-links of SF3B6 with SF3B1. Crosslinked residues are depicted by circles connected by a reddish-brown line, where the numbers indicate the positions of the crosslinked amino acids. c, Crosslinks of SF3B3WD40B with PRP4K. Labeling as in panel b. d, Left and middle, U2 snRNP is connected to the poorly-resolved, globular EM density by a thin density element. Right, the latter protrudes from SF3B1HEAT at the position where the 3’ end of the intron was previously shown to exit the HEAT domain. Thus, this density is predicted to contain intron nucleotides between the BS and 3’ss, and the adjacent, poorly-defined globular domain highly likely contains the MINX exon and bound SR proteins, as well as U1 snRNP. e, Distance constraints exclude an alternative pre-B protomer organization. The distance between U1 and U2 SF3B1HEAT in pre-B protomers organized as shown in Fig. 1 (left), and in an alternatively-organized protomer (right) are shown. For simplicity, only one of the U1 snRNPs is shown in each cartoon. Panel 2d shows that there is continuous density that links U2 SF3B1 of one promoter to the exon/U1 snRNP-containing globular density (GD) that is attached to PRP28 of the other protomer. Following this density, the distance between SF3B1 of one protomer and PRP28 of the other promoter would require ca 30 nts of RNA to cover. A similar RNA length would be required to reach the U1 bound to the 5’ss in the adjacent GD. Thus, our placement of the U1 snRNP is consistent with the 39 nt length of the MINX exon plus ca 10 nts of the PPT/3’ss that extend beyond SF3B1HEAT. In the alternative organization, the same U2 snRNP, but instead the U1 from the other GD, would bind to the same MINX exon RNA substrate (and thus in this case U1 would interact in cis with PRP28). This would require that after exiting SF3B1HEAT, the remaining PPT/3’ss nts plus the MINX exon would wrap back across SF3B1HEAT and extend to PRP28 (and to the adjacent U1) within the same protomer. However, this would require more than 60 nts to cover this distance, without clashing with any tri-snRNP proteins, which is much longer than the length of our exon (39 nts) plus ca 10 nts of the PPT/3’ss that extend beyond SF3B1HEAT. Alternative RNA paths that extend along the other side of the complex would be even longer. Therefore, an exon much longer than 60 nts would be required to form such an intra-protomer complex. Thus, in our CE pre-B complexes, PRP28 cannot interact within the same protomer with the U1 snRNP-bound 5’ss. f, Representative EM 2D class of the CE pre-B complex dimer. The “fuzzy” nature of the globular domains containing U1 and the exon binding proteins is likely due to the transient interaction of various SR proteins with the exon. g, Model of cross-exon, protein-protein interactions that indirectly bridge the U2 and U1 snRNPs in the CE pre-B complex based on protein crosslinking of the CE pre-B complex (see also Supplementary Table S2). Crosslinked residues are connected by black arrows. Although the cryo-EM structure of a cross-exon pre-A complex was recently reported38, the nature of the bridge connecting the U2 and U1 snRNPs could not be discerned due to the poor resolution in this region of the complex. SR proteins are likely recruited to the defined exon by exonic splicing enhancers, as well as to the U1 snRNP39, and have long been proposed to establish a network of protein-protein interactions across the exon that link the U2 and U1 snRNPs40–42. The number and identity of the SR proteins interacting with the exon likely varies from one cross-exon complex to the next43. Thus, there may be different combinations of SR proteins bound compared to those depicted in the model. The RRMs of SRSF1 crosslink with the U1-70K RRM, consistent with previous biochemical studies44. Likewise, RBM39 crosslinks to U2AF, and the LUC7L paralogs LUC7L2 and LUC7L3 (labeled LUC7L) crosslink to several SR proteins. The U1-related protein PRPF40A crosslinks to U1-70K, U1-A and LUC7L3, consistent with previous studies revealing similar interactions of PRP40 in the yeast U1 snRNP in early splicing complexes45,46. With the exception of a crosslink between SF3A1 and PRPF40A, crosslinks between U1 and U2 snRNP proteins are not observed, supporting the conclusion that U2 and U1 do not directly contact one another in cross-exon complexes, as previously proposed. The U1 snRNA stem-loop 4 was previously shown to interact with the U2 SF3A1 protein during the early stages of cross-intron spliceosome assembly47. However, it is not clear whether this RNA-protein interaction, which would directly connect U1 and U2 snRNP, contributes to the molecular bridge linking U1 and U2 in cross-exon complexes.
Fig 2: PRPF6 promoted tumorigenesis, and PTX-resistance in vitro and in vivo. (A), PTX resistance were examined by CCK8 viability assays after overexpressed PRPF6 and silencing PRPF6, (B), GATA3, N-cadherin, E-cadherin, β-tubulin III, and vimentin were detected by western blotting after silencing PRPF6. (C) SKOV3-TR30 cells were stably transfected with lentivirus containing the siPRPF6 sequence. The cells were injected in 4-week-old female BALB/cA-nu mice (N = 3/group). PTX (20 mg/kg) or saline was injected into the tumor every 3 days for 3 weeks. Images of tumors were pictured. (D) Tumor expansion was measured every 3 days (tumor volume = length × width 2/2). (E) Tumor weight was measured. *p < 0.05, **p < 0.01, ***p < 0.001 (n = 3).
Fig 3: PRPF6 upregulated GATA3 expression through SNHG16-L to further induced EMT and PTX resistance. (A) GATA3, N-cadherin, E-cadherin, β-tubulin III, and vimentin expression was examined by western blotting after overexpression of PRPF6 and SNHG16-L. (B) PRPF6 and GATA3 expression in the previous xenograft tumor tissues was tested through IHC. *p < 0.05, **p < 0.01, ***p < 0.001 (n = 3).
Fig 4: PRPF6 promoted cell growth, migration and invasion of OC. Silencing PRPF6 in SKOV3-TR30 and overexpressing PRPF6 in SKOV3, (A) Cell growth was analyzed through CCK8 assays, (B) cell colony proliferation was detected using colony formation experiment, (C), cell migration and invasion were detected by transwell assays. *p < 0.05, **p < 0.01, ***p < 0.001 (n = 3).
Fig 5: Cryo-EM and image-processing of the cross-exon B-like complex.a, RNA composition of the purified B-like dimers. B-like complexes were affinity-purified and RNA from the fastest-sedimenting gradient peak was isolated, separated on a NuPAGE gel, and visualized by staining with SyBr gold. For gel source data, see Supplementary Fig. 1. The nucleotide (nts) lengths of the snRNAs and MINX exon RNA are indicated on the right. The RNA composition was analysed from four independent B-like complex purifications with similar results. U1 snRNA, which due to the presence of an excess of the 5’ss oligo should no longer be base paired to the 5’ss of the MINX exon RNA (see panel I) is still present, together with U2, U4, U5 and U6 snRNA, and the MINX exon RNA. It is very likely that, under our low salt purification conditions, U1 snRNP remains bound via protein-protein interactions presumably in the vicinity of the MINX 5’ss (i.e., in the upper poorly-resolved, globular EM density). Substantial amounts of U1 are also observed in all other complexes incubated in the presence of an excess of the 5’ss oligo (see below). b, Representative cryo-EM 2D class averages of the CE B-like dimers. c, Cryo-EM computation sorting scheme for CE B-like complexes. All major image-processing steps are depicted. The tri-snRNP core is comprised of all tri-snRNP components excluding the U4 Sm core, U5 Sm core and BRR2. The U4/U6 part consists of the U4/U6 stems I and II and associated proteins. d, Local resolution estimation of the tri-snRNP core region of the B-like complex. e, Orientation distribution plot for the particles contributing to the reconstruction of the tri-snRNP core region. f, Fourier shell correlation (FSC) values for the listed parts of the B-like complex, indicate a resolution of 3.1 Å for the tri-snRNP core, 4.3 Å for BRR2, 3.3 Å for the U4/U6 snRNP and 12 Å for the U2 snRNP. g, Map versus model FSC curves generated for the tri-snRNP core, BRR2 and U4/U6 regions of B-like using PHENIX mtriage. h-i, Structure of the CE B-like dimers (panel h) and CI B dimers23 (panel i). Upper panels, overview of the 3D organization of the dimers. Middle and lower panels, expanded views of interface 1 and 2, respectively. Note that the view of the interfaces is from the top of the complexes shown in the upper panels. As in the CI hB dimer23, the B-like dimer is organized in a parallel manner with U5 located at the bottom of both protomers. Both dimers contain an upper, poorly defined globular density. Based on the position of the thin density bridges adjacent to SF3B1HEAT, in both dimers the upper globular density appears to contain the MINX exon and associated proteins, and may additionally contain loosely-associated U1 snRNP. The two protomers in the B-like and B dimers are connected in the middle by an interface involving SMU1 and its binding partner RED, the PRP6 N-terminal HAT domains, and SNU66 α−helix200-219. The CI B dimers contain a large globular density element that is located at the very bottom, close to the exit site of the 5’ exon in each protomer, suggesting that this density element is comprised of the 5’ exons and associated proteins23. Consistent with this idea, CE B-like dimers, which lack an upstream 5’ exon, do not possess this large globular density. This supports the idea that the poorly-defined globular densities indeed are comprised of exons and exon-interacting proteins. In B-like, the lower interface 2 is comprised of unassigned density that separates SNU114 and MFAP1 from one protomer with SNU114 and MFAP1 from the other protomer. The functional relevance of these interfaces, as well as dimer formation in general, is currently not known. j, Fit of the nucleotides and protein side chains shown in Fig. 2b (left) and 2d (right) into the B-like EM density. k, Schematic of the RNA-RNA interaction network in the B-like complex. Two copies of the 5’ss-containing RNA oligonucleotide (5’ss oligo), which is added in excess, base pair not only with U1 (disrupting the U1/5’ss helix), but also with the U6 snRNA at/near the ACAGA box and with U5 snRNA loop 1. The resulting extended U6/5’ss helix is not as long as the bona fide extended U6/5’ss helix that is formed in the human B complex19,22. A dot between two nucleotides indicates that they do not base pair, but that a helix involving these nucleotides is formed (e.g., the extended U2/BS or U6/5’ss helices).
Supplier Page from Abcam for Anti-PRP6/ANT-1 antibody